You are adding an alert for:
Comparing intravitreal bevacizumab and sub threshold macular laser (STML) in the initial treatment of diabetic macular edema (DME) in a resident lead clinic.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: